Because these come from separate trials with different participants, the figures cant be read as a direct comparison
The number on the price tag is rarely the most important number
Both support weight loss with compounded GLP-1s
In the key obesity trial, adults with obesity but without type 2 diabetes received weekly subcutaneous injections of retatrutide at varying doses over a 24-week period
Highlights of Prescribing Information: Contrave (naltrexone- hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use
It reads pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 to describe your baseline appetite-regulation and energy-balance biology, giving you and your provider genetic context that a GLP-1 prescription alone does not capture